Does Rallies show 13F holders for NBY?

Yes. Rallies tracks hedge fund and 13F ownership data for NBY, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NBY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NBY. It does not provide personalized investment advice.

NBY (NovaBay Pharmaceuticals, Inc.) Stock Analysis - Hedge Fund Holdings

NovaBay Pharmaceuticals, Inc. (NBY) is a publicly traded Healthcare sector company. As of May 21, 2026, NBY trades at $1.95 with a market cap of $51.92M and a P/E ratio of 0.12. NBY moved +23.42% today. Year to date, NBY is -62.14%; over the trailing twelve months it is -31.82%. Its 52-week range spans $1.11 to $99.75. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces NBY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NBY stock?

Hedge funds tracked by Rallies that own NBY include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NovaBay Pharmaceuticals, Inc..

NBY Key Metrics

Key financial metrics for NBY
Metric	Value
Price	$1.95
Market Cap	$51.92M
P/E Ratio	0.12
EPS	$16.10
Dividend Yield	0.80%
52-Week High	$99.75
52-Week Low	$1.11
Volume	637.60K
Avg Volume	0
Revenue (TTM)	$2.46M
Net Income	$522.59M
Gross Margin	0.00%

Top Hedge Funds Holding NBY

Exoduspoint Capital holds 20.16K shares of NBY, changed +0.00% as of Dec 31, 2025.

Latest NBY News

Stablecoin Development Corporation Secures $134M, Holds 8.78% of SKY Token Supply — Mar 23, 2026

Recent NBY Insider Trades

POPLAR POINT CAPITAL PARTNERS LP bought 300 (~$139.5) on Apr 8, 2025.
POPLAR POINT CAPITAL PARTNERS LP bought 4.54K (~$2.37K) on Apr 4, 2025.
POPLAR POINT CAPITAL PARTNERS LP bought 22.98K (~$12.93K) on Apr 3, 2025.

NBY Analyst Consensus

5 analysts cover NBY: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.

Common questions about NBY

Who owns NBY stock?: Hedge funds tracked by Rallies that own NBY include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for NovaBay Pharmaceuticals, Inc..
Does Rallies show 13F holders for NBY?: Yes. Rallies tracks hedge fund and 13F ownership data for NBY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NBY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NBY. It does not provide personalized investment advice.